A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

Bayer

Status: Completed

Conditions: Rhinitis, Allergic

Treatments: Other: Online survey

Study type: Observational

Funder types: Industry

Identifiers

NCT04645979

21614

Details and patient eligibility

About

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Enrollment: 153 patients

Sex: All

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis
• Participants allowing to use the data for research and marketing purposes as well as talking to authorities
• Participants allowing us to use the pseudo-randomized individual data for further data analysis
• Able to read and understand the language of the online questionnaire

Exclusion criteria

• None

Trial design

153 participants in 1 patient group

Participants

Description:

Participants who used betamethasone plus loratadine to treat allergic rhinitis within the previous two months.

Treatment:

Other: Online survey